Results 171 to 180 of about 115,037 (313)
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 253-255, March 2025.
Robert Greig +4 more
wiley +1 more source
Objectives Gastroesophageal reflux during anaesthesia is a common event occurring in dogs with the potential to cause oesophageal injury and aspiration pneumonia. The objective of the current study was to evaluate the effect of the novel metabotropic glutamate receptor 5 antagonist TT001 on gastroesophageal reflux during anaesthesia in dogs using two ...
A. Glovéus +4 more
wiley +1 more source
Clinical &Experimental Allergy, Volume 55, Issue 3, Page 264-266, March 2025.
Kirsten E. Stewart +3 more
wiley +1 more source
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng +3 more
wiley +1 more source
Abstract In patients previously hospitalised for COVID‐19, a 12‐week high‐intensity interval training (HIIT) intervention has previously been shown to increase left ventricular mass (LVM) immediately after the intervention. In the present study, we examined the effects of the same HIIT scheme on LVM, pulmonary diffusing capacity, symptom severity and ...
Iben Elmerdahl Rasmussen +21 more
wiley +1 more source
Development of an Intelligent Clinical Decision Support System for Spirometry Quality Control. [PDF]
López-Canay J +7 more
europepmc +1 more source
The effect on participation rates of including focused spirometry information in a health check invitation: a cluster-randomised trial in Denmark [PDF]
Lene Maria Ørts +6 more
openalex +1 more source
Type‐2 Biomarkers, Asthma Diagnosis and Lung Function Impairment in the General Population
Clinical &Experimental Allergy, EarlyView.
Sebastian Riemann +2 more
wiley +1 more source

